Ultra-processed food is causing a boom for obesity drug Ozempic
The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs. One example…
Metabolic Disorders
-
-
Strong Wegovy revenue growth for Novo Nordisk but shares dip
Novo Nordisk has reported net Q3 profits of $3.94bn (DKr27.3bn) fuelled by better-than-expected sales for its blockbuster weight loss drug…
-
NLS and Kadimastem stocks soar following merger agreement
Switzerland-based NLS Pharmaceutics and Israel-headquartered Kadimastem have signed a definitive merger agreement, with plans to form a joint biopharmaceutical aimed…
-
Lexicon stock tumbles after FDA AdCom votes against Zynquista again
The US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (AdCom) has again voted against the approval…
-
Pharmacists claim “desperation” by Novo Nordisk over semaglutide copycat block
In the same week that Eli Lilly filed three lawsuits against online vendors and wellness spas making compounded versions of…
-
MangoRx hits back at Eli Lilly’s weight loss drug copycat claims
MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for sale on…
-
Novo Nordisk plans label expansion for Rybelsus following Phase III win
Novo Nordisk plans to file a label expansion for Rybelsus (oral semaglutide) as an adjunct treatment for the prevention of…
-
TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D
TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin), a type 2 diabetes (T2D) treatment, to patients…
-
Lexicon partners Viatris for global expansion of sotagliflozin
Lexicon Pharmaceuticals has entered a licensing agreement with Viatris, granting the latter exclusive rights to commercialise sotagliflozin in all indications…
-
Eli Lilly will ‘build new way of doing science’ in UK amid £297m pledge to government
An Eli Lilly executive has said the company will “build a new way of doing science” as part of its…
